Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Understanding drug resistance is a primary challenge in the successful treatment of breast cancer. This professional text by Springer provides an in-depth look at the molecular details and functional consequences of endocrine resistance. Written by experts in the field, the book addresses how tumor cells develop or possess intrinsic resistance to bypass therapeutic constraints. Readers will gain access to recent research regarding the mechanisms of cancer drug resistance. The content focuses on how these biological processes lead to treatment failure and explores the potential of new molecular targets. By examining current studies, the book highlights how novel drug combinations may be applied in future clinical settings to improve patient outcomes in oncology.